Navigation Links
Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis
Date:12/17/2009

WALTHAM, MA Brandeis University selected Jay and Maureen Neitz, the husband-and-wife team whose pioneering research may lead to the use of gene therapy to treat vision disorders, as the inaugural recipients of the Jay Pepose '75 Award in Vision Sciences.

The award is funded by a $1 million endowment established this year through a gift from Brandeis graduates Jay Pepose '75 and Susan K. Feigenbaum '74, his wife. The endowment primarily supports graduate research fellowships in vision science.

The Neitzes, both of whom are faculty members in the Department of Ophthalmology at the University of Washington in Seattle, will visit Brandeis to receive the Pepose Award. They will each deliver a public lecture in Gerstenzang 121: Jay will discuss "Gene Therapy for Red-Green Color Blindness in Adult Primates" at 3:30 p.m. on Feb. 8, and Maureen will talk about "Retinal Activity Patterns and the Cause and Prevention of Nearsightedness" at noon on Feb. 9.

Pepose is a professor of clinical ophthalmology at Washington University and the owner and medical director of the Pepose Vision Institute in St. Louis. During his time as an undergraduate, Pepose worked closely with John Lisman, the Zalman Abraham Kekst Chair in Neuroscience and Professor of Biology at Brandeis. He was part of the inaugural class of Fellows inducted into the Association for Research in Vision and Ophthalmology (ARVO) in 2009.

"We look forward to the Neitzes' visit to campus to discuss their groundbreaking research," said Brandeis President Jehuda Reinharz, PhD '72. "We thank Jay and Susan, whose gift to establish the Pepose Award in Vision Sciences has made it possible for Brandeis faculty and students to learn more about the Neitzes' work."

In a recent issue of the journal Nature, the Neitzes and their colleagues detailed a study in which they used gene therapy to cure two squirrel monkeys of color blindness. The research offers hope for the use of gene therapy to treat adult vision disorders involving cone cells the most important cells for vision in humans.

"The Neitzes' recent paper in Nature will revolutionize the way we understand color perception," Pepose said. "I am delighted that Brandeis has chosen such outstanding contributors to vision research for this award."


'/>"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
Source:Eurekalert

Related medicine news :

1. Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division
2. Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference
3. PAL Browser, Helpful Software Available for Those with Mobility and Vision Problems
4. Early Treatment of Hearing, Vision Helps in Schizophrenia
5. Enhanced Vision Named as one of Orange County's Top Workplaces in 2009
6. LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes
7. VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution
8. New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director
9. Brandeis studies evaluate visionary approach to improving eyesight
10. NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions
11. Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: